State Board of Administration of Florida Retirement System’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $859K | Sell |
25,732
-68,096
| -73% | -$1.69M | ﹤0.01% | 1377 |
|
|
2026
Q1 | $1.97M | Sell |
93,828
-3,008
| -3% | -$67.7K | ﹤0.01% | 1032 |
|
|
2025
Q4 | $2.23M | Buy |
96,836
+4,070
| +4% | +$134K | ﹤0.01% | 1008 |
|
|
2025
Q3 | $2.79M | Sell |
92,766
-1,143
| -1% | -$34.3K | ﹤0.01% | 935 |
|
|
2025
Q2 | $3.41M | Buy |
93,909
+470
| +0.5% | +$16.9K | 0.01% | 889 |
|
|
2025
Q1 | $3.38M | Hold |
93,439
| – | – | 0.01% | 871 |
|
|
2024
Q4 | $3.93M | Buy |
93,439
+3,870
| +4% | +$192K | 0.01% | 849 |
|
|
2024
Q3 | $4.98M | Hold |
89,569
| – | – | 0.01% | 802 |
|
|
2024
Q2 | $3.68M | Buy |
89,569
+1,896
| +2% | +$81K | 0.01% | 857 |
|
|
2024
Q1 | $3.52M | Buy |
87,673
+2,104
| +2% | +$99.2K | 0.01% | 843 |
|
|
2023
Q4 | $4.09M | Buy |
85,569
+1,087
| +1% | +$42.1K | 0.01% | 855 |
|
|
2023
Q3 | $3.01M | Buy |
84,482
+200
| +0.2% | +$7.92K | 0.01% | 896 |
|
|
2023
Q2 | $3.89M | Sell |
84,282
-3,391
| -4% | -$157K | 0.01% | 858 |
|
|
2023
Q1 | $3.52M | Hold |
87,673
| – | – | 0.01% | 867 |
|
|
2022
Q4 | $4.06M | Sell |
87,673
-3,040
| -3% | -$120K | 0.01% | 823 |
|
|
2022
Q3 | $3.76M | Hold |
90,713
| – | – | 0.01% | 848 |
|
|
2022
Q2 | $5.41M | Buy |
90,713
+5,162
| +6% | +$318K | 0.01% | 767 |
|
|
2022
Q1 | $6.21M | Sell |
85,551
-1,101
| -1% | -$76.6K | 0.01% | 790 |
|
|
2021
Q4 | $7.29M | Buy |
86,652
+439
| +0.5% | +$35.7K | 0.01% | 764 |
|
|
2021
Q3 | $7.78M | Sell |
86,213
-2,040
| -2% | -$184K | 0.02% | 744 |
|
|
2021
Q2 | $8.41M | Buy |
88,253
+64,228
| +267% | +$6.69M | 0.02% | 739 |
|
|
2021
Q1 | $2.73M | Sell |
24,025
-1,820
| -7% | -$248K | 0.01% | 1007 |
|
|
2020
Q4 | $3.58M | Sell |
25,845
-3,060
| -11% | -$363K | 0.01% | 947 |
|
|
2020
Q3 | $2.38M | Buy |
28,905
+580
| +2% | +$48.1K | 0.01% | 991 |
|
|
2020
Q2 | $2.22M | Sell |
28,325
-560
| -2% | -$37.1K | 0.01% | 990 |
|
|
2020
Q1 | $1.28M | Hold |
28,885
| – | – | ﹤0.01% | 1084 |
|
|
2019
Q4 | $1.23M | Sell |
28,885
-150
| -0.5% | -$6.19K | ﹤0.01% | 1275 |
|
|
2019
Q3 | $1.24M | Hold |
29,035
| – | – | ﹤0.01% | 1242 |
|
|
2019
Q2 | $1.84M | Buy |
29,035
+2,600
| +10% | +$165K | ﹤0.01% | 1079 |
|
|
2019
Q1 | $1.83M | Hold |
26,435
| – | – | ﹤0.01% | 1075 |
|
|
2018
Q4 | $1.15M | Buy |
26,435
+116
| +0.4% | +$6.34K | ﹤0.01% | 1273 |
|
|
2018
Q3 | $2.01M | Hold |
26,319
| – | – | 0.01% | 1102 |
|
|
2018
Q2 | $2.02M | Buy |
26,319
+1,100
| +4% | +$71K | 0.01% | 1088 |
|
|
2018
Q1 | $1.29M | Buy |
25,219
+137
| +0.5% | +$6.9K | ﹤0.01% | 1301 |
|
|
2017
Q4 | $1.16M | Buy |
25,082
+760
| +3% | +$37.3K | ﹤0.01% | 1376 |
|
|
2017
Q3 | $1.29M | Hold |
24,322
| – | – | ﹤0.01% | 1315 |
|
|
2017
Q2 | $1.51M | Hold |
24,322
| – | – | ﹤0.01% | 1195 |
|
|
2017
Q1 | $1.65M | Hold |
24,322
| – | – | ﹤0.01% | 1165 |
|
|
2016
Q4 | $1.71M | Hold |
24,322
| – | – | 0.01% | 1137 |
|
|
2016
Q3 | $1.73M | Sell |
24,322
-20
| -0.1% | -$1.28K | 0.01% | 1109 |
|
|
2016
Q2 | $1.19M | Buy |
24,342
+1,335
| +6% | +$86.4K | ﹤0.01% | 1289 |
|
|
2016
Q1 | $1.46M | Buy |
23,007
+1,000
| +5% | +$65.4K | 0.01% | 1201 |
|
|
2015
Q4 | $2.47M | Buy |
22,007
+1,390
| +7% | +$139K | 0.01% | 963 |
|
|
2015
Q3 | $1.99M | Buy |
20,617
+15,266
| +285% | +$1.75M | 0.01% | 1062 |
|
|
2015
Q2 | $548K | Buy |
+5,351
| New | +$415K | ﹤0.01% | 1902 |
|
Other funds holding RARE
EHI
N
PAM
PFM
State Board of Administration of Florida Retirement System's RARE Position: Q2 2026 in Review
State Board of Administration of Florida Retirement System reduced its Ultragenyx Pharmaceutical (RARE) stake by 73% in Q2 2026, selling an estimated $1.69M and leaving 25,732 shares worth $859K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.
State Board of Administration of Florida Retirement System first reported a position in RARE in Q2 2015 and has held it in 45 quarters since. The position peaked at $8.41M in Q2 2021. 126 funds tracked by Wall St. Rank hold RARE as of Q2 2026.
- State Board of Administration of Florida Retirement System held 25,732 shares of Ultragenyx Pharmaceutical worth $859K as of Q2 2026.
- State Board of Administration of Florida Retirement System sold 68,096 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.69M.
- Ultragenyx Pharmaceutical made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1377 holding.
- State Board of Administration of Florida Retirement System first reported a position in Ultragenyx Pharmaceutical in Q2 2015 and has held it in 45 quarters since.
- State Board of Administration of Florida Retirement System's Ultragenyx Pharmaceutical position peaked at $8.41M in Q2 2021.
- 126 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.